Skip to main content
Prof. Joanna Kalucka joins Bonn as a Mercator Fellow and investigates how metabolic and inflammatory processes affect the inner lining of blood vessels.
© Aarhus University / Lars Kruse

News categories: Honors & Funding

Joanna Kalucka Joins Bonn as a Mercator Fellow

Joanna Kalucka, Associate Professor at Aarhus University’s Department of Biomedicine, will join the Collaborative Research Centre (CRC) 1454 “Metaflammation and Cellular Programming” at the University of Bonn and Bonn University Hospital (UKB) as a Mercator Fellow Global from 2027. The German Research Foundation (DFG) is funding her fellowship through the “1000 Heads Plus” programme of the Federal Ministry of Research, Technology and Space (BMFTR).

Prof. Joanna Kalucka studies the biology of blood vessels under healthy and pathological conditions. At the CRC, she will investigate how the vascular endothelium, the inner lining of blood vessels, responds to metabolic stress caused by obesity and lifestyle factors and how this affects its function. A particular focus will be on how endothelial cells develop immunoregulatory properties and influence communication between blood vessels and the immune system during chronic inflammation, such as metaflammation.

“Her expertise in communication between the vascular endothelium and immune cells adds an important perspective to our research on metaflammation,” says Prof. Dr Dagmar Wachten, spokesperson of CRC 1454 and Director at the Institute of Innate Immunity at UKB, as well as a member of the ImmunoSensation³ Cluster of Excellence and the University of Bonn’s Transdisciplinary Research Area (TRA) “Modelling”. “We look forward to gaining new scientific perspectives and strengthening collaboration within the CRC.”

Joanna Kalucka will also contribute to the ImmunoSensation³ Cluster of Excellence and the University of Bonn’s TRA “Life and Health”.

About the “Mercator Fellow Global” programme

The “Mercator Fellow Global” module is part of the “Global Minds in DFG-funded Research Consortia” initiative within the “1000 Heads Plus” programme of the Federal Ministry of Research, Technology and Space (BMFTR). The funding enables DFG-funded research consortia to integrate researchers working abroad into their activities as fellows for an extended period, even if they are not currently planning a permanent move to the German research system.

Further information: DFG – Global Minds Initiative Germany

The image shows a network of blood vessels (purple) running through adipose tissue. The white-highlighted cells illustrate the diversity of cell types within these vessels. Their functions will be studied in greater detail in Bonn as part of the Mercator Fellowship.
The image shows a network of blood vessels (purple) running through adipose tissue. The white-highlighted cells illustrate the diversity of cell types within these vessels. Their functions will be studied in greater detail in Bonn as part of the Mercator Fellowship.
© Aarhus University / Ibrahim Alzaim and Thomas Phillips

Press contacts

Theresa Vonderheit
Science Management – Communications
CRC 1454 Metaflammation and Cellular Programming
Tel.: +49 151 16857 542
Email: theresa.vonderheit@ukbonn.de

Dr. Inka Väth
Deputy Press Spokesperson, Bonn University Hospital (UKB)
Communications and Media Office, Bonn University Hospital
Tel.: +49 228 287-10596
Email: inka.vaeth@ukbonn.de

Related news

Prof. Christian Henneberger, Direktor des Instituts für Zelluläre Neurowissenschaften I am UKB, und Prof. Susanne Schoch McGovern,
Prof. Christian Henneberger, Direktor des Instituts für Zelluläre Neurowissenschaften I am UKB, und Prof. Susanne Schoch McGovern, - Direktorin des Instituts für Zelluläre Neurowissenschaften II am UKB, sind Sprecher und stellvertretende Sprecherin der neuen DFG-Forschungsgruppe FOR 5987. Der Forschungsverbund untersucht, wie Botenstoffe Informationen im Gehirn innerhalb und außerhalb von Synapsen übertragen.

News categories: Honors & Funding

How Far Do Signalling Molecules Act Beyond the Boundaries of a Synapse?

—The German Research Foundation (DFG) is establishing a new Research Unit entitled “Inside and Outside the Synapse: Challenging Dogmas of Synaptic Signalling and Neuromodulation.” The research consortium is headed by Prof. Christian Henneberger from Bonn University Hospital (UKB) and the University of Bonn, with Prof. Susanne Schoch McGovern, also from the UKB and the University of Bonn. Together with researchers from the UKB, the University of Bonn, the DZNE and the University of Göttingen, they will investigate how signalling molecules transmit information in the brain.
View entry
Sieglinde Tyczka und Frederick Tyczka-Christoph zu Besuch in der Bonner Universitäts-Augenklinik. - von links: Prof. Dr. Uwe Reuter, Vorstandsvorsitzender und Ärztlicher Vorstand des UKB, Frederick Tyczka-Christoph, Sieglinde Tyczka, Prof. Dr. Frank G. Holz, Direktor der Augenklinik am UKB.

News categories: Honors & Funding

One Million Euros for Restoring Vision in Age-Related Macular Degeneration

—The Tyczka family of entrepreneurs is supporting research into restoring vision in patients with age-related macular degeneration (AMD) with a donation of one million euros. The funding will support the research project “AI-supported optimisation of vision restoration using retinal implants” at the Department of Ophthalmology at Bonn University Hospital (UKB). The aim of the project is to further develop and optimise the application of innovative retinal implant technology, which recently received European CE marking as a medical device.
View entry
25 Millionen Euro für die Bonner KI-Krebsforschung: (v.l.) Prof. Dr. Bernd Weber, Prof. Dr. Michael Hölzel, Prof. Dr. Jürgen Bajorath und Prof. Dr. Uwe Reuter, beim Auftakt von AI4CancerCure.NRW in der Staatskanzlei Nordrhein-Westfalen.

News categories: Honors & Funding

€25 Million for AI-Powered Cancer Research in Bonn

—University Hospital Bonn (UKB), the University of Bonn and the Lamarr Institute for Machine Learning and Artificial Intelligence are using funding from the state of North Rhine-Westphalia to establish a joint research infrastructure. The aim is to use AI to design and optimize potential cancer therapeutics and subsequently test them in the laboratory. Minister-President Hendrik Wüst and Minister of Science Ina Brandes presented the funding commitment today at the State Chancellery of North Rhine-Westphalia.
View entry

Back to the news overview